Safa Kaleem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Safa Kaleem has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Anne Sai Nitya Tejaswi
Gandhi Medical College & Hospital, Department of Internal Medicine, Secunderabad, Telangana, India
1 shared publication- Bollu Sashank Sai
Gandhi Medical College & Hospital, Department of Internal Medicine, Secunderabad, Telangana, India
1 shared publication - Faizan Ahmad
Jamia Hamdard
1 shared publication Fouziya Shaikh
Krishna Institute of Medical Science, Karad, India
1 shared publication- Lyluma Ishfaq
Government medical college, Srinagar, Directorate of health services Kashmir Srinagar, J&k , India
1 shared publication Mallica Sanadhya
Lady Hardinge Medical College, India
1 shared publication
Latest Publications
- Open Access
- 17 April 2025
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 66 (6) , 515-521
Critical appraisal on neural tube defects and their complexities
- 17 April 2025
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 66 (6) , 515-521
Open AccessCritical appraisal on neural tube defects and their complexities
- Open Access
- 21 September 2023
- Published by Springer Nature in Research Square
Impact of Proton Pump Inhibitors on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review
Aim: The aim of this systematic review is to comprehensively assess and analyze the impact of proton pump inhibitors on kidney function and their potential role in the progression of chronic kidney disease. Through a meticulous examination of available literature, we aim to provide a clear understanding of the relationship between proton pump inhibitor use and kidney health, shedding light on potential risks, benefits, and contributing factors. Ultimately, this research aims to inform healthcare professionals and patients alike about the implications of proton pump inhibitors on kidney function, facilitate informed medical decisions, and improve patient care. Methods: We used the following medical subject headings (MeSH) terms with keywords like "irritable bowel syndrome" and "kidney injury" to gather data from the National Library of Medicine (PubMed), PubMed Central (PMC), and Google Scholar. Articles from the last 10 years, 2013 to 2023, were gathered for this systematic review. Results: The results indicate a complex relationship between proton pump inhibitors and kidney function, as well as the progression of chronic kidney disease. Conclusion: In the end, this systematic review shows that there is a link between long-term use of proton pump inhibitors and a higher risk of kidney problems. Patients and healthcare providers should weigh the benefits of proton pump inhibitor therapy against potential risks, especially in individuals with pre-existing kidney conditions, and consider alternative treatment options when appropriate. Regular monitoring of kidney function in proton pump inhibitor users may also be advisable to ensure early detection and management of any adverse effects.
- 21 September 2023
- Published by Springer Nature in Research Square
Open AccessImpact of Proton Pump Inhibitors on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review
Aim: The aim of this systematic review is to comprehensively assess and analyze the impact of proton pump inhibitors on kidney function and their potential role in the progression of chronic kidney disease. Through a meticulous examination of available literature, we aim to provide a clear understanding of the relationship between proton pump inhibitor use and kidney health, shedding light on potential risks, benefits, and contributing factors. Ultimately, this research aims to inform healthcare professionals and patients alike about the implications of proton pump inhibitors on kidney function, facilitate informed medical decisions, and improve patient care. Methods: We used the following medical subject headings (MeSH) terms with keywords like "irritable bowel syndrome" and "kidney injury" to gather data from the National Library of Medicine (PubMed), PubMed Central (PMC), and Google Scholar. Articles from the last 10 years, 2013 to 2023, were gathered for this systematic review. Results: The results indicate a complex relationship between proton pump inhibitors and kidney function, as well as the progression of chronic kidney disease. Conclusion: In the end, this systematic review shows that there is a link between long-term use of proton pump inhibitors and a higher risk of kidney problems. Patients and healthcare providers should weigh the benefits of proton pump inhibitor therapy against potential risks, especially in individuals with pre-existing kidney conditions, and consider alternative treatment options when appropriate. Regular monitoring of kidney function in proton pump inhibitor users may also be advisable to ensure early detection and management of any adverse effects.